CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Planned sale Chief Legal Officer sold 2,607 shares at $60.11 ($156,702)
- 4 Planned sale PRESIDENT & CEO sold 281,269 shares at an average $60.32 ($16,966,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT & CEO sold 40,000 shares at an average $44.43 ($1,777,093)
- 4 Planned sale PRESIDENT & CEO sold 25,205 shares at an average $45.33 ($1,142,513)
- 4 Planned sale PRESIDENT & CEO sold 97 shares at $45.01 ($4,366)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale PRESIDENT, CEO & INTERIM CFO sold 25,000 shares at $40.16 ($1,004,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 3 shares at $30.48 ($91)
- 4 Derivatives Options or other derivatives
Page 2 of 19 · 370 filings